S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
Log in
NASDAQ:SGEN

Seagen Short Interest Ratio and Short Volume

$179.23
-0.93 (-0.52 %)
(As of 12/4/2020 12:00 AM ET)
Add
Compare
Today's Range
$178.46
Now: $179.23
$182.03
50-Day Range
$164.63
MA: $179.90
$204.49
52-Week Range
$90.57
Now: $179.23
$213.94
Volume566,553 shs
Average Volume1.11 million shs
Market Capitalization$32.32 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.13

Short Interest

Seagen (NASDAQ:SGEN) Short Interest Data

Current Short Volume:3,680,000 shares
Previous Short Volume:3,500,000 shares
Change Vs. Previous Month:+5.14%
Dollar Volume Sold Short:$626.74 million
Short Interest Ratio / Days to Cover:4.0
Last Record Date:November, 15 2020
Outstanding Shares:168,860,000 shares
Short Percent of Float:0.00%
Today's Trading Volume:566,553 shares
Average Trading Volume:1,109,103 shares
Today's Volume Vs. Average:-48.92%



Seagen (NASDAQ:SGEN) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
11/15/20203,680,000 $626.74 million 5.1%0.0%3.7$170.31
10/30/20203,500,000 $615.69 million -8.9%0.0%3.7$175.91
10/15/20203,840,000 $756.17 million -11.9%0.0%4.1$196.92
9/30/20204,360,000 $924.01 million 7.9%0.0%4.5$211.93
9/15/20204,040,000 $747.20 million 5.8%0.0%4$184.95
8/31/20203,820,000 $564.14 million 1.9%0.0%4$147.68
8/14/20203,750,000 $576.23 million -1.8%0.0%3.4$153.66
7/31/20203,820,000 $615.06 million -4.3%0.0%3.2$161.01
7/15/20203,990,000 $663.42 million -5.2%0.0%3.1$166.27
6/30/20204,210,000 $710.73 million -8.7%0.0%3.2$168.82
6/15/20204,610,000 $771.44 million -1.3%0.0%3.5$167.34
5/29/20204,670,000 $769.62 million -3.5%0.0%3.4$164.80
5/15/20204,840,000 $760.90 million 6.6%0.0%3.5$157.21
4/30/20204,540,000 $694.48 million -10.3%0.0%3.5$152.97
4/15/20205,060,000 $814.46 million -3.8%0.0%4.3$160.96
3/31/20205,260,000 $768.17 million 7.0%0.0%4.5$146.04
3/13/20204,916,100 $591.51 million 17.6%0.0%3.6$120.32
2/28/20204,180,000 $414.95 million -15.7%0.0%3.7$99.27
2/14/20204,960,000 $532.90 million -14.8%0.0%4.5$107.44
1/31/20205,820,000 $652.48 million 17.6%0.0%5.2$112.11
1/15/20204,950,000 $583.85 million -5.5%0.0%4.4$117.95
12/31/20195,240,000 $595.11 million 2.5%0.0%4.5$113.57
10/15/20196,940,000 $752.30 million 2.5%4.2%7.5$108.40

Seagen (NASDAQ:SGEN) Short Interest FAQ

speech bubbles
speech bubbles











What is Seagen's current short interest?

Short interest is the volume of Seagen shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 3,680,000 shares of SGEN short. 0.00% of Seagen's shares are currently sold short. View details.

What is a good short interest ratio for Seagen?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Seagen currently has a short interest ratio of 4.0.

Is Seagen's short interest increasing or decreasing?

Seagen saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 3,680,000 shares, an increase of 5.1% from the previous total of 3,500,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Seagen's short interest compare to its competitors?

0.00% of Seagen's shares are currently sold short. Here is how the short interest of companies in the sub-industry of "biotechnology" compare to Seagen: Amgen Inc. (1.29%), Gilead Sciences, Inc. (1.74%), Regeneron Pharmaceuticals, Inc. (1.97%), Biogen Inc. (2.42%), Alexion Pharmaceuticals, Inc. (1.89%), Exact Sciences Co. (0.00%), Incyte Co. (0.00%), Alnylam Pharmaceuticals, Inc. (0.00%), BioMarin Pharmaceutical Inc. (0.00%), and Repligen Co. (3.38%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.96 billion), Aon Plc ($3.87 billion), Moderna, Inc. ($3.77 billion), Analog Devices, Inc. ($3.62 billion), Snap Inc. ($3.05 billion), The Clorox Company ($2.80 billion), The Kroger Co. ($2.11 billion), International Flavors & Fragrances Inc. ($1.98 billion), Expedia Group, Inc. ($1.95 billion), and Peloton Interactive, Inc. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Seagen stock?

Short selling SGEN is an investing strategy that aims to generate trading profit from Seagen as its price is falling. Seagen's stock is trading down $0.93 today. To short Seagen stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Seagen will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Seagen?

A short squeeze for Seagen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SGEN, which in turn drives the price of the stock up even further.

How often is Seagen's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SGEN, twice per month. The most recent reporting period available is November, 15 2020.


This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.